HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuhisa Ono Selected Research

Kazuhisa Ono Research Topics

Disease

5Allergic Rhinitis
01/2017 - 10/2007
5Seasonal Allergic Rhinitis (Hay Fever)
01/2017 - 01/2010
5Atopic Dermatitis (Atopic Eczema)
01/2010 - 01/2004
4Inflammation (Inflammations)
11/2018 - 11/2002
4Hypersensitivity (Allergy)
01/2017 - 01/2002
3Dermatitis
01/2010 - 01/2004
3Eczema
02/2008 - 03/2005
2Sepsis (Septicemia)
11/2018 - 06/2014
2Acute Lung Injury
11/2018 - 06/2014
2Neoplasms (Cancer)
06/2018 - 06/2018
2Leukemia
01/2017 - 01/2011
2Conjunctivitis
01/2010 - 02/2004
2Rhinitis
01/2010 - 02/2004
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2018
1Adenocarcinoma of Lung
06/2018
1Immediate Hypersensitivity
01/2017
1Asthma (Bronchial Asthma)
01/2016
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
06/2014
1Hepatocellular Carcinoma (Hepatoma)
02/2014
1Sneezing
01/2011
1Autoimmune Hepatitis
04/2010
1Hepatitis
04/2010
1Autolysis
01/2010
1Hyperuricemia
01/2010
1Splenomegaly
02/2008
1Lymphadenopathy
02/2008
1Hypercholesterolemia
10/2007
1Mastocytosis
01/2007
1Respiratory Hypersensitivity
11/2002

Drug/Important Bio-Agent (IBA)

10Immunoglobulin E (IgE)IBA
01/2017 - 01/2004
8AllergensIBA
10/2016 - 02/2004
6(1-6)-alpha-glucomannan (glucomannan)IBA
01/2010 - 01/2004
2EnzymesIBA
11/2018 - 01/2010
2LipopolysaccharidesIBA
11/2018 - 06/2014
2PhytochemicalsIBA
06/2018 - 01/2017
2Anti-Allergic Agents (Antiallergic Agents)IBA
01/2017 - 04/2012
2Histones (Histone)IBA
01/2016 - 04/2010
2VaccinesIBA
04/2012 - 01/2002
2OvalbuminIBA
01/2011 - 10/2007
2Peptide Hydrolases (Proteases)FDA Link
11/2010 - 01/2010
2CytokinesIBA
11/2010 - 03/2005
2AutoantibodiesIBA
04/2010 - 02/2008
2PowdersIBA
03/2005 - 01/2004
1NAD (NADH)IBA
11/2018
1Caspase 9IBA
06/2018
1Cyclin-Dependent Kinases (cdk Proteins)IBA
06/2018
1bosutinibIBA
06/2018
1CaspasesIBA
06/2018
1Tyrosine Kinase InhibitorsIBA
06/2018
1Caspase 3 (Caspase-3)IBA
06/2018
1Proteins (Proteins, Gene)FDA Link
06/2018
1Dasatinib (BMS 354825)FDA Link
06/2018
1ponatinibIBA
06/2018
1nilotinibFDA Link
06/2018
1flavanoneIBA
01/2017
1PolyphenolsIBA
01/2017
1aluminum sulfate (alum)IBA
01/2016
1Neutralizing AntibodiesIBA
01/2016
1ovalbumin-alumIBA
01/2016
1Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA
06/2014
1fucoxanthinIBA
02/2014
1fucoxanthinolIBA
02/2014
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
02/2014
1Carotenoids (Carotene)IBA
02/2014
1salicylhydroxamic acid (SHAM)IBA
01/2011
1NF-kappa B (NF-kB)IBA
04/2010
1Concanavalin AIBA
04/2010
1Mitogen-Activated Protein KinasesIBA
04/2010
1CalcineurinIBA
04/2010
1gamma-Aminobutyric Acid (GABA)IBA
01/2010
1Uric Acid (Urate)IBA
01/2010
1AntibodiesIBA
01/2010
1Rheumatoid FactorIBA
02/2008
1Immunoglobulin G (IgG)IBA
02/2008
1B-Cell Activating FactorIBA
02/2008
1Substance PIBA
01/2007
1AntigensIBA
11/2002
1Acetylcholine (Acetylcholine Chloride)FDA Link
11/2002

Therapy/Procedure

3Oral Administration
01/2017 - 01/2010